Evidence map›Paper›PMID 38637422›Full record

ArticleMolecular biology reports2024

Silymarin and MSC-exosomes ameliorate thioacetamide-evoked renal fibrosis by inhibiting TGF-β/SMAD pathway in rats.

Dina Mohamed Mekawy, Dina Sabry, Rania Mohamed Sabry, Naglaa F Abozeid

Open access · hybridAbstract read
In one paragraph

Article in Molecular biology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dina Mohamed MekawyMedical Biochemistry and Molecular Biology Department, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, 11956, Egypt.
Dina SabryMedical Biochemistry and Molecular Biology Department, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, 11956, Egypt.
Rania Mohamed SabryDepartment of Anatomic Pathology, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, 11956, Egypt.
Naglaa F AbozeidMedical Biochemistry and Molecular Biology Department, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, 11956, Egypt. naglaafathy@kasralainy.edu.eg.
Cairo University · EGBadr University in Cairo · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTGF-β1 and SMAD3 are particularly pathogenic in the progression of renal fibrosis.

aimThis study aimed to evaluate the kidney protective potentials of silymarin (SM) and exosomes of mesenchymal stem cells against the nephrotoxin thioacetamide (TAA) in rats.

methods32 female rats were randomly assigned into four groups: the control group, the TAA group, the TAA + SM group, and the TAA + Exosomes group. The kidney homogenates from all groups were examined for expression levels of TGF-β receptors I and II using real-time PCR, expression levels of collagen type I and CTGF proteins using ELISA, and the expression levels of nuclear SMAD2/3/4, cytoplasmic SMAD2/3, and cytoplasmic SMAD4 proteins using the western blot technique.

resultsCompared to the control group, the injection of TAA resulted in a significant increase in serum levels of urea and creatinine, gene expression levels of TβRI and TβRII, protein expression levels of both collagen I and CTGF proteins, cytoplasmic SMAD2/3 complex, and nuclear SMAD2/3/4 (p-value < 0.0001), with significantly decreased levels of the co-SMAD partner, SMAD4 (p-value < 0.0001). Those effects were reversed considerably in both treatment groups, with the superiority of the exosomal treatment regarding the SMAD proteins and the expression levels of the TβRI gene, collagen I, and CTGF proteins returning to near-control values (p-value > 0.05).

conclusionUsing in vitro and in vivo experimental approaches, the research discovered a reno-protective role of silymarin and exosomes of BM-MSCs after thioacetamide-induced renal fibrosis in rats, with the advantage of exosomes.

Indexed as

ExosomesKidney DiseasesSilymarinAnimalsCollagen Type IFemaleFibrosisRatsSmad ProteinsThioacetamideTransforming Growth Factor betaTransforming Growth Factor beta1Collagen Type ISilymarinSmad ProteinsThioacetamideTransforming Growth Factor betaTransforming Growth Factor beta1ExosomesMSCsSilymarinTGFThioacetamide

Identifiers

PMID38637422
PMCPMC11026270
OpenAlexW4394933803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.